Trial intelligence / Profile preview

N-acetylcysteine versus placebo for prevention of treatment-induced oral mucositis in children with cancer

IRCT20210622051666N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in stomatitis comparing N-acetylcysteine with Placebo control (2 arms). Primary endpoint: Efficacy of N-acetylcysteine in prevention of mucositis caused by radiotherapy. Started Jul 2023; status: completed.

02

Drugs

acetylcysteine
03

Conditions

stomatitis

Beyond the preview

Go deeper on IRCT20210622051666N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210622051666N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call